Second series C tranche brings in £4m for fungal test co:
This article was originally published in Clinica
Executive Summary
University of Manchester spin-out Myconostica has raised £3.9m ($7.8m) in the second tranche of its series C financing, bringing the total investment in that round to £4.4m. The financing was led by Amphion, which owns 25% of Myconostica, and included the participation of Nexus Medical Partners, Innoven Partenaires and other UK and international investors.